These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11509874)

  • 21. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge.
    Bukh J; Engle RE; Faulk K; Wang RY; Farci P; Alter HJ; Purcell RH
    J Virol; 2015 Sep; 89(17):9128-32. PubMed ID: 26085160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.
    Christiansen D; Earnest-Silveira L; Chua B; Meuleman P; Boo I; Grubor-Bauk B; Jackson DC; Keck ZY; Foung SKH; Drummer HE; Gowans EJ; Torresi J
    Sci Rep; 2018 Apr; 8(1):6483. PubMed ID: 29691437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
    Elmowalid GA; Qiao M; Jeong SH; Borg BB; Baumert TF; Sapp RK; Hu Z; Murthy K; Liang TJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8427-32. PubMed ID: 17485666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.
    Barth H; Rybczynska J; Patient R; Choi Y; Sapp RK; Baumert TF; Krawczynski K; Liang TJ
    Hepatology; 2011 Oct; 54(4):1135-48. PubMed ID: 21674561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The development of therapeutic vaccine for hepatitis C virus].
    Kimura K; Kohara M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1451-7. PubMed ID: 23064054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
    Bukh J
    J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
    Park SH; Shin EC; Capone S; Caggiari L; De Re V; Nicosia A; Folgori A; Rehermann B
    Gastroenterology; 2012 Oct; 143(4):1048-60.e4. PubMed ID: 22705008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
    Christiansen D; Earnest-Silveira L; Chua B; Boo I; Drummer HE; Grubor-Bauk B; Gowans EJ; Jackson DC; Torresi J
    Viral Immunol; 2018 May; 31(4):338-343. PubMed ID: 29489437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods to Evaluate Novel Hepatitis C Virus Vaccines.
    Ahlén G; Frelin L
    Methods Mol Biol; 2016; 1403():221-44. PubMed ID: 27076133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
    Torresi J; Johnson D; Wedemeyer H
    J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
    Singh S; Vedi S; Samrat SK; Li W; Kumar R; Agrawal B
    PLoS One; 2016; 11(1):e0146404. PubMed ID: 26751211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
    Morin TJ; Broering TJ; Leav BA; Blair BM; Rowley KJ; Boucher EN; Wang Y; Cheslock PS; Knauber M; Olsen DB; Ludmerer SW; Szabo G; Finberg RW; Purcell RH; Lanford RE; Ambrosino DM; Molrine DC; Babcock GJ
    PLoS Pathog; 2012; 8(8):e1002895. PubMed ID: 22952447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
    Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives for a hepatitis C virus vaccine.
    Abrignani S; Rosa D
    Clin Diagn Virol; 1998 Jul; 10(2-3):181-5. PubMed ID: 9741644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.
    Rzymski P; Jibril AT; Rahmah L; Abarikwu SO; Hashem F; Lawati AA; Morrison FMM; Marquez LP; Mohamed K; Khan A; Mushtaq S; Minakova K; Poniedziałek B; Zarębska-Michaluk D; Flisiak R
    J Med Virol; 2024 Sep; 96(9):e29900. PubMed ID: 39234788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.